Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recombination activating gene and its defects.

A Villa1, C Sobacchi, P Vezzoni

  • 1Istituto di Tecnologie Biomediche, Consiglio Nazionale delle Ricerche, Segrate, Italy. villa@itba.mi.cnr.it

Current Opinion in Allergy and Clinical Immunology
|April 20, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Test of Lepton Flavor Universality with B_{s}^{0}→ϕℓ^{+}ℓ^{-} Decays.

Physical review letters·2025
Same author

Observation of the Open-Charm Tetraquark Candidate T_{cs0}^{*}(2870)^{0} in the B^{-}→D^{-}D^{0}K_{S}^{0} Decay.

Physical review letters·2025
Same author

Study of Λ_{b}^{0} and Ξ_{b}^{0} Decays to Λh^{+}h^{'-} and Evidence for CP Violation in Λ_{b}^{0}→ΛK^{+}K^{-} Decays.

Physical review letters·2025
Same author

First Evidence for Direct CP Violation in Beauty to Charmonium Decays.

Physical review letters·2025
Same author

First Determination of the Spin-Parity of Ξ_{c}(3055)^{+,0} Baryons.

Physical review letters·2025
Same author

Measurement of the Branching Fraction Ratios R(D^{+}) and R(D^{*+}) Using Muonic τ Decays.

Physical review letters·2025
Same journal

Biosimilars in allergology: an outline in pediatric patients.

Current opinion in allergy and clinical immunology·2026
Same journal

The immunogenetic landscape of systemic lupus erythematosus.

Current opinion in allergy and clinical immunology·2026
Same journal

Circadian control of innate immunity: molecular mechanisms and implications for allergic disorders.

Current opinion in allergy and clinical immunology·2026
Same journal

Probiotics in allergic disease: from adjunct supplement to immune-modifying strategy (2026 update).

Current opinion in allergy and clinical immunology·2026
Same journal

Updates on drug-induced anaphylaxis in children.

Current opinion in allergy and clinical immunology·2026
Same journal

Beta-lactam de-labelling as a core antimicrobial stewardship strategy in the era of the antimicrobial resistance pandemic: a narrative review.

Current opinion in allergy and clinical immunology·2026
See all related articles

Mutations in recombination activating genes (RAG) cause severe combined immunodeficiencies. Residual RAG activity, not just genetic background, determines the specific clinical presentation, from T-B SCID to Omenn syndrome.

Area of Science:

  • Immunology
  • Genetics
  • Molecular Biology

Background:

  • Mutations in recombination activating genes (RAG) lead to severe combined immunodeficiencies (SCID).
  • SCID presents a spectrum of clinical manifestations, including T-B SCID and Omenn syndrome (T+ B- SCID).
  • Clinical variability may be influenced by environmental factors and genetic background.

Purpose of the Study:

  • To investigate the determinants of clinical variability in SCID caused by RAG mutations.
  • To understand the role of residual RAG activity in shaping the immunodeficiency phenotype.

Main Methods:

  • Analysis of patient data with RAG mutations.
  • Assessment of residual recombination activating gene activity.
  • Correlation of RAG activity levels with clinical phenotypes.

Related Experiment Videos

Main Results:

  • Residual RAG activity is a primary determinant of clinical presentation in RAG-deficient SCID.
  • Lower levels of residual RAG activity correlate with specific SCID phenotypes, such as Omenn syndrome.
  • The degree of recombinational events, influenced by residual RAG activity, explains the spectrum of immunodeficiency.

Conclusions:

  • Residual recombination activating gene activity is the key factor differentiating SCID subtypes.
  • Understanding RAG activity levels can predict the clinical course of SCID.
  • This finding highlights the importance of quantitative assessment of RAG function in diagnosing and managing SCID.